PATENT CLAIM ANALYSIS

Application Number: 15760449
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-03
Patent Classification: ["514", "001100"]

Abstract:
Provided herein are polypeptides which include tenth fibronectin type III domains ( 10 Fn3) that bind to glypican-3. Also provided are fusion molecules comprising a  10 Fn3 domain that bind to glypican-3 for use in diagnostic and therapeutic applications. Glypican-3  10 Fn3 drug conjugates are also provided.

Claim (Index 34):
The polypeptide of  claim 33 , wherein the heterologous moiety is a detectable moiety, or a drug moiety wherein the FBS and drug moiety form an FBS-drug conjugate.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.34211
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15529260', '14481641', '14025307', '15282277', '14355155']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7478213396109482
- 35 USC 102 Novelty (BERT): 0.5363394343968982
- Combined Prediction Score: 0.7266731490895433
- Mean Citation Score: 309.929192
- Max Citation Score: 336.22153
- Similarity Product: 204.81114609923543

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test